• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsParatek Pharmaceuticals
    Picture of Paratek Pharmaceuticals logo

    PRTK — Paratek Pharmaceuticals News Story

    $2.230.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall Cap
    • Market Cap
      $127.83m
    • Enterprise Value
      $343.47m
    • Revenue
      $160.27m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PRTK Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PRTK Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 05:00 PM

    Picture of Paratek Pharmaceuticals logoParatek Pharmaceuticals
    18/12/2019 22:00
    NASDAQ TRADE HALT  PRTK.O  HALT NEWS PENDING AT 05:00 PM
    

    Recent news on Paratek Pharmaceuticals

    See all news
    • Novo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals

      21/09/2023 17:26
    • Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings

      12/09/2023 13:26
    • Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30

      11/09/2023 13:39
    • Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings

      07/09/2023 20:36
    • Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million

      03/08/2023 14:49

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.